Skip to main content

Epidermoid Cyst

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
1
Sodium Tetradecyl SulfatePhase 21 trial
Active Trials
NCT05597995Unknown10Est. May 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Fitzpatrick CompanySodium Tetradecyl Sulfate

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

NCT05597995Fitzpatrick CompanySodium Tetradecyl Sulfate

Treatment of Epidermoid Cysts

Start: Nov 2022Est. completion: May 202310 patients
Phase 2Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.